Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St set to open higher as jobs data dampens rate hike odds, yields fall
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
April 25, 2024 5:30 AM EDTSanofi (NASDAQ: SNY) saw its shares jump 5% in premarket trading Thursday after the company posted better-than-expected business operating profit for the fiscal Q1.
The pharmaceutical company reported Q1 earnings per share (EPS) of EUR 1.78, surpassing the consensus estimate of EUR 0.93. Revenue for the quarter stood at EUR 10.46... More
